Renalytix released their budget impact analysis a few days ago, coming up with savings of $1.05B per 100,000 patients over 5 years.
I could be very wrong as I've only made a very low effort comparison but on a high level it seems to endorse PIQ's analysis of circa $0.64B per 100,000 over 5 years. (PIQ said 389b over 10 years in a 31m patient population).
Not really related to the report but for some reason reading it made me look at Renalytix (and their $1.5b mc!!) again.
Ann: Annual Report to shareholders, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.65M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 38.0¢ | $98.01K | 252.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9722 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 44999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |